Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population

被引：0
|
作者：
Domingo Hernandez
Ana Espejo-Gil
M Rosa Bernal-Lopez
Jose Mancera-Romero
Antonio J Baca-Osorio
Francisco J Tinahones
Ana M Armas-Padron
Pedro Ruiz-Esteban
Armando Torres
Ricardo Gomez-Huelgas
机构：
[1] Hospital Regional Universitario Carlos Haya,Nephrology Department
[2] Hospital Regional Universitario Carlos Haya,Internal Medicine Department
[3] Hospital Virgen de la Victoria,Biomedical Research Laboratory, Endocrinology Department
[4] Instituto de Salud Carlos III,Ciber Fisiopatologia de la Obesidad y Nutricion
[5] Health Care “Ciudad Jardin”,Endocrinology Department
[6] Hospital Virgen de la Victoria,Research Unit
[7] Health Care “La Cuesta”,undefined
[8] Hospital Universitario de Canarias,undefined
来源：
BMC Nephrology | / 14卷
关键词：
Glycated hemoglobin; Chronic kidney disease; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prospective Association Among Diabetes Diagnosis, HbA1c, Glycemia, and Frailty Trajectories in an Elderly Population
    Aguayo, Gloria A.
    Hulman, Adam
    Vaillant, Michel T.
    Donneau, Anne-Francoise
    Schritz, Anna
    Stranges, Saverio
    Malisoux, Laurent
    Huiart, Laetitia
    Guillaume, Michele
    Sabia, Severine
    Witte, Daniel R.
    DIABETES CARE, 2019, 42 (10) : 1903 - 1911
  • [32] Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% Results From the CREDENCE Trial
    Cannon, Christopher P.
    Perkovic, Vlado
    Agarwal, Rajiv
    Baldassarre, James
    Bakris, George
    Charytan, David M.
    de Zeeuw, Dick
    Edwards, Robert
    Greene, Tom
    Heerspink, Hiddo J. L.
    Jardine, Meg J.
    Levin, Adeera
    Li, Jing-Wei
    Neal, Bruce
    Pollock, Carol
    Wheeler, David C.
    Zhang, Hong
    Zinman, Bernard
    Mahaffey, Kenneth W.
    CIRCULATION, 2020, 141 (05) : 407 - 410
  • [33] The interference by HbF on HbA1c (BM Test HbA1c) measurement in enzymatic method
    Nitta, Takenori
    Yamashiro, Yasuhiro
    Hattori, Yukio
    Ezumi, Tomoko
    Nishioka, Mituaki
    Nakamura, Junji
    ANNALS OF CLINICAL BIOCHEMISTRY, 2015, 52 (05) : 569 - 575
  • [34] Use of labile HbA1c as a screening tool to minimize clinical misinterpration of HbA1c
    De Muynck, Emilie
    Lapauw, Bruno
    Delanghe, Joris
    Lambrecht, Stijn
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024,
  • [35] The association of HbA1C and cTnI with mortality and severity of disease among patients with acute coronary syndrome
    Sheikh, Mahboobeh
    Ostadrahimi, Pouya
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (03) : 626 - 631
  • [36] HbA1c and Metabolic Syndrome
    Swislocki, Arthur
    METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (06) : 391 - 393
  • [37] Beyond HbA1c cardiovascular protection in type 2 diabetes mellitus
    Adamu, U. G.
    Mpanya, D.
    Patel, A.
    Tsabedze, N.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2023, 28 (01) : 7 - 13
  • [38] HbA1c: a useful cardiovascular risk marker in those without diabetes?
    D. Preiss
    N. Sattar
    Diabetologia, 2010, 53 : 2468 - 2469
  • [39] Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease
    Saba, Luca
    Ikeda, Nobutaka
    Deidda, Martino
    Araki, Tadashi
    Molinari, Filippo
    Meiburger, Kristen M.
    Acharya, U. Rajendra
    Nagashima, Yoshinori
    Mercuro, Giuseppe
    Nakano, Masataka
    Nicolaides, Andrew
    Suri, Jasjit S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (03) : 348 - 353
  • [40] Low HbA1c and mortality: causation and confounding
    Rutter, M. K.
    DIABETOLOGIA, 2012, 55 (09) : 2307 - 2311
12345